free email | research | news | portfolio | charts
 UBBFriend: Email This Page to Someone! |
 Investorville
 D
 Deltagen (DGEN)
|
| next newest topic | next oldest topic |
| Author | Topic: Deltagen (DGEN) |
|
InvestorGuide Daily Administrator |
posted 08-03-2000 06:35 PM
 
Gene function information company Deltagen (DGEN) priced at $15 opened at $18, closed at $19, and raised $105 million. |
|
Mayor of Investorville Administrator |
posted 04-17-2000 10:47 AM
Deltagen, a development-stage biotech company, hopes its technology can generate, analyze, and study genetic information more quickly than existing systems. Drug companies subscribe to its DeltaBase database of mammalian gene functions and use its DeltaSelect target-validation program to select and validate drug-discovery targets. Using DeltaBase, Deltagen delivers knockout mice (in which the targeted gene function has been "knocked out") for drug-candidate testing. The firm has also developed Delta-GT that identifies the function of secreted proteins in mammals. Deltagen's customers include Pfizer (64% of sales), Roche Biosciences, Merck, Schering-Plough, and Tularik. The company plans to raise $100 million but an IPO date hasn't been set yet. (source: SEC filing) |
All times are EST (US) | next newest topic | next oldest topic |
  |
|
Powered by: Ultimate Bulletin Board, Version 5.43
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.
Press ctrl-D to bookmark this page for future reference.
By using this site you agree to our Terms of Use.
Copyright 1999 InvestorGuide.com Inc.